trial

AIMHI NT Relapse Prevention Trial

NCTId NCT00192582
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 90
Sponsored by Menzies School of Health Research
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
90
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2005-07
Primary completion
—
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Motivational Interview with care plan and education

Sponsors

Menzies School of Health ResearchLead Sponsor
National Health and Medical Research Council, AustraliaCollaborator
Alcohol Education and rehabilitation FundCollaborator
Cooperative Research Centre for Aboriginal HealthCollaborator
Northern Territory Government of AustraliaCollaborator

Investigators

1
Tricia M Nagel, MBBS, FRANZCPPrincipal Investigator

Sites

1 total
Darwin, Australia

Facts & assertions

3 sourced
Enrollment
90
Phase
NA
Status
UNKNOWN
relationships
The graph out of here
drug
Motivational Interview with care plan and education
drug
lead_sponsor
Menzies School of Health Research
company
collaborator
National Health and Medical Research Council, Australia
company
Alcohol Education and rehabilitation Fund
company
indication
Bipolar Disorder
indication
Psychoses, Substance-Induced
indication
Schizoaffective Disorder
indication
investigator
Tricia M Nagel, MBBS, FRANZCP
person